Prognostic impact of Charlson’s Age-Comorbidity Index and other risk factors in patients with pancreatic cancer
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Prognostic impact of Charlson’s Age-Comorbidity Index and other risk factors in patients with pancreatic cancer. / Bagni, Karin; Chen, Inna M.; Johansen, Astrid Z.; Dehlendorff, Christian; Jensen, Benny V.; Hansen, Carsten P.; Preus Hasselby, Jane; Holländer, Niels H.; Nissen, Mette; Bjerregaard, Jon K.; Pfeiffer, Per; Yilmaz, Mette K.; Rasmussen, Louise S.; Nielsen, Svend E.; Johansen, Julia S.
In: European Journal of Cancer Care, Vol. 29, No. 3, e13219, 05.2020.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Prognostic impact of Charlson’s Age-Comorbidity Index and other risk factors in patients with pancreatic cancer
AU - Bagni, Karin
AU - Chen, Inna M.
AU - Johansen, Astrid Z.
AU - Dehlendorff, Christian
AU - Jensen, Benny V.
AU - Hansen, Carsten P.
AU - Preus Hasselby, Jane
AU - Holländer, Niels H.
AU - Nissen, Mette
AU - Bjerregaard, Jon K.
AU - Pfeiffer, Per
AU - Yilmaz, Mette K.
AU - Rasmussen, Louise S.
AU - Nielsen, Svend E.
AU - Johansen, Julia S.
PY - 2020/5
Y1 - 2020/5
N2 - Objectives: Few studies have evaluated the impact of risk factors and comorbidity on overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). The aim was to investigate the prognostic importance of Charlson's age-comorbidity index (CACI) and other risk factors on prognosis in a clinical real-world cohort of PDAC patients. Methods: A total of 1,159 patients with PDAC who had received at least one cycle of adjuvant or palliative chemotherapy were included from the Danish BIOPAC study. We analysed OS according to CACI, tobacco smoking, alcohol intake, performance status (PS), BMI and diabetes. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for OS using Cox proportional hazards regression. Results: At the end of follow-up, 994 (86%) patients had died. The median OS was 298 days for all patients (range 3–3010) and shortest in patients with stage IV. No association with short OS was seen for CACI > 2, diabetes, alcohol abuse, tobacco smoking, hypertension, and high BMI. Multivariate analysis showed that stage (IV vs. I: HR = 9.05, 95% CI 5.17–15.84), PS (2 vs. 0: HR = 3.67, 2.92–4.61) and treatment with angiotensin-converting enzyme inhibitors (yes vs. no: HR = 1.31, 1.06–1.61) were independent negative prognostic factors. Conclusions: We found that CACI, diabetes, tobacco smoking, alcohol abuse, hypertension, and high BMI were not associated with OS in a real-world cohort of patients with PDAC treated with chemotherapy. Only stage and PS were prognostic parameters.
AB - Objectives: Few studies have evaluated the impact of risk factors and comorbidity on overall survival (OS) in patients with pancreatic ductal adenocarcinoma (PDAC). The aim was to investigate the prognostic importance of Charlson's age-comorbidity index (CACI) and other risk factors on prognosis in a clinical real-world cohort of PDAC patients. Methods: A total of 1,159 patients with PDAC who had received at least one cycle of adjuvant or palliative chemotherapy were included from the Danish BIOPAC study. We analysed OS according to CACI, tobacco smoking, alcohol intake, performance status (PS), BMI and diabetes. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated for OS using Cox proportional hazards regression. Results: At the end of follow-up, 994 (86%) patients had died. The median OS was 298 days for all patients (range 3–3010) and shortest in patients with stage IV. No association with short OS was seen for CACI > 2, diabetes, alcohol abuse, tobacco smoking, hypertension, and high BMI. Multivariate analysis showed that stage (IV vs. I: HR = 9.05, 95% CI 5.17–15.84), PS (2 vs. 0: HR = 3.67, 2.92–4.61) and treatment with angiotensin-converting enzyme inhibitors (yes vs. no: HR = 1.31, 1.06–1.61) were independent negative prognostic factors. Conclusions: We found that CACI, diabetes, tobacco smoking, alcohol abuse, hypertension, and high BMI were not associated with OS in a real-world cohort of patients with PDAC treated with chemotherapy. Only stage and PS were prognostic parameters.
KW - Age-Comorbidity Index
KW - BMI
KW - Charlson
KW - diabetes
KW - pancreatic cancer
KW - risk factors
KW - survival
U2 - 10.1111/ecc.13219
DO - 10.1111/ecc.13219
M3 - Journal article
C2 - 31908093
AN - SCOPUS:85077875081
VL - 29
JO - European Journal of Cancer Care
JF - European Journal of Cancer Care
SN - 0961-5423
IS - 3
M1 - e13219
ER -
ID: 244370280